Apremilast: pooled safety analysis of three phase 3, randomized, controlled trials in patients with psoriatic arthritis

被引：0
|
作者：
Schett, G. [1 ]
Mease, P. J. [2 ,3 ]
Kavanaugh, A. [4 ]
Adebajo, A. O. [5 ]
Gomez-Reino, J. J. [6 ]
Wollenhaupt, J. [7 ]
Cutolo, M. [8 ]
Lespessailles, E. [9 ]
Shah, K.
Hu, C.
Stevens, R.
Edwards, C. [10 ]
Birbara, C. [11 ]
机构：
[1] Univ Erlangen Nurnberg, D-91054 Erlangen, Germany
[2] Swedish Med Ctr, Seattle, WA USA
[3] Univ Washington, Sch Med, Seattle, WA USA
[4] Univ Calif San Diego, San Diego, CA 92103 USA
[5] Univ Sheffield, Sheffield, S Yorkshire, England
[6] Hosp Clin Univ, Santiago, Spain
[7] Schon Klin Hamburg Eilbek, Hamburg, Germany
[8] Univ Genoa, Genoa, Italy
[9] Univ Orleans, Orleans, France
[10] Southampton Univ Hosp, Southampton, Hants, England
[11] Univ Massachusetts, Sch Med, Worcester, MA USA
来源：
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY | 2013年 / 27卷
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
P012
引用
收藏
页码：6 / 6
页数：1
相关论文
共 50 条
  • [1] Apremilast: pooled safety analysis of three phase 3, randomized, controlled trials in patients with psoriatic arthritis
    Schett, G.
    Mease, P.
    Kavanaugh, A.
    Adebajo, A.
    Gomez-Reino, J.
    Wollenhaupt, J.
    Cutolo, M.
    Lespessailles, E.
    Shah, K.
    Hu, A.
    Stevens, R.
    Edwards, C.
    Birbara, C.
    ZEITSCHRIFT FUR RHEUMATOLOGIE, 2013, 72 : 122 - 122
  • [2] APREMILAST: POOLED SAFETY ANALYSIS OF THREE PHASE 3, RANDOMIZED, CONTROLLED TRIALS IN PATIENTS WITH PSORIATIC ARTHRITIS
    Mease, P. J.
    Kavanaugh, A.
    Adebajo, A. O.
    Gomez-Reino, J. J.
    Wollenhaupt, J.
    Cutolo, M.
    Schett, G.
    Lespessailles, E.
    Shah, K.
    Hu, C.
    Stevens, R.
    Edwards, C. J.
    Birbara, C. A.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 685 - 685
  • [3] Laboratory Abnormalities In Patients With Psoriatic Arthritis Receiving Apremilast, An Oral Phosphodiesterase 4 Inhibitor: Pooled Safety Analysis Of Three Phase 3, Randomized, Controlled Trials
    Mease, Philip J.
    Kavanaugh, Arthur
    Adebajo, Adewale O.
    Gomez-Reino, Juan J.
    Wollenhaupt, Juergen
    Gladman, Dafna D.
    Cutolo, Maurizio
    Schett, Georg
    Lespessailles, Eric
    Shah, Kamal
    Hu, ChiaChi
    Stevens, Randall M.
    Edwards, Christopher J.
    Birbara, Charles A.
    ARTHRITIS AND RHEUMATISM, 2013, 65 : S151 - S151
  • [4] Long-term safety and tolerability of apremilast, an oral phosphodiesterase 4 inhibitor, in patients with psoriatic arthritis: pooled safety analysis of three phase 3, randomized controlled trials
    Adebajo, A.
    Mease, P.
    Kavanaugh, A.
    Gladman, D.
    Gomez-Reino, J.
    Wollenhaupt, J.
    Cutolo, M.
    Schett, G.
    Lespessailles, E.
    Shah, K.
    Hu, C. C.
    Stevens, R.
    Edwards, C.
    Birbara, C.
    SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2014, 43 : 68 - 69
  • [5] LONG-TERM SAFETY AND TOLERABILITY OF APREMILAST, AN ORAL PHOSPHODIESTERASE 4 INHIBITOR, IN PATIENTS WITH PSORIATIC ARTHRITIS: POOLED SAFETY ANALYSIS OF THREE PHASE 3, RANDOMIZED, CONTROLLED TRIALS
    Mease, P. J.
    Kavanaugh, A.
    Gladman, D.
    Adebajo, A. O.
    Gomez-Reino, J. J.
    Wollenhaupt, J.
    Cutolo, M.
    Schett, G.
    Lespessailles, E.
    Shah, K.
    Hu, C.
    Stevens, R.
    Edwards, C.
    Birbara, C.
    ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 742 - 743
  • [6] Long-Term Safety and Tolerability Of Apremilast, An Oral Phosphodiesterase 4 Inhibitor, In Patients With Psoriatic Arthritis: Pooled Safety Analysis Of Three Phase 3, Randomized, Controlled Trials
    Mease, Philip J.
    Kavanaugh, Arthur
    Gladman, Dafna D.
    Adebajo, Adewale O.
    Gomez-Reino, Juan J.
    Wollenhaupt, Juergen
    Cutolo, Maurizio
    Schett, Georg
    Lespessailles, Eric
    Shah, Kamal
    Hu, ChiaChi
    Stevens, Randall M.
    Edwards, Christopher J.
    Birbara, Charles A.
    ARTHRITIS AND RHEUMATISM, 2013, 65 : S131 - S132
  • [7] Long-Term Safety and Tolerability of Apremilast, an Oral Phosphodiesterase 4 Inhibitor, in Patients with Psoriatic Arthritis: Pooled Safety Analysis of Three Phase 3, Randomized, Controlled Trials
    Mease, Philip
    Kavanaugh, Arthur
    Gladman, Dafna
    Adebajo, Adewale
    Gomez-Reino, Juan
    Wollenhaupt, Juergen
    Cutolo, Maurizio
    Schett, Georg
    Lespessailles, Eric
    Shah, Kamal
    Hu, ChiaChi
    Stevens, Randall
    Edwards, Christopher
    Birbara, Charles
    JOURNAL OF RHEUMATOLOGY, 2014, 41 (07) : 1551 - 1552
  • [8] Long-Term Safety and Tolerability of Apremilast Versus Placebo in Psoriatic Arthritis: A Pooled Safety Analysis of Three Phase III, Randomized, Controlled Trials
    Mease, Philip J.
    Gladman, Dafna D.
    Gomez-Reino, Juan J.
    Hall, Stephen
    Kavanaugh, Arthur
    Lespessailles, Eric
    Schett, Georg
    Paris, Maria
    Delev, Nikolay
    Teng, Lichen
    Wollenhaupt, Juergen
    ACR OPEN RHEUMATOLOGY, 2020, 2 (08) : 459 - 470
  • [9] LONG-TERM (104-WEEK) SAFETY PROFILE OF APREMILAST, AN ORAL PHOSPHODIESTERASE 4 INHIBITOR, IN PATIENTS WITH PSORIATIC ARTHRITIS: POOLED SAFETY ANALYSIS OF THREE PHASE 3, RANDOMIZED, CONTROLLED TRIALS
    Mease, P.
    Adebajo, A.
    Gladman, D.
    Gomez-Reino, J.
    Hall, S.
    Kavanaugh, A.
    Lespessailles, E.
    Schett, G.
    Shah, K.
    Teng, L.
    Wollenhaupt, J.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 355 - 356
  • [10] Long-Term (104 Week) Safety Profile of Apremilast, an Oral Phosphodiesterase 4 Inhibitor, in Patients with Psoriatic Arthritis: Pooled Safety Analysis of Three Phase III, Randomized, Controlled Trials
    Mease, Philip J.
    Adebajo, Adewale O.
    Gladman, Dafna D.
    Gomez-Reino, Juan J.
    Hall, Stephen
    Kavanaugh, Arthur
    Lespessailles, Eric
    Schett, Georg A.
    Shah, Kamal
    Teng, Lichen
    Wollenhaupt, Juergen
    ARTHRITIS & RHEUMATOLOGY, 2015, 67
12345